Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Legend Biotech Corporation - American Depositary Shares
(NQ:
LEGN
)
33.35
-2.13 (-6.00%)
Streaming Delayed Price
Updated: 3:28 PM EDT, Jun 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Legend Biotech Corporation - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
A Glimpse Into The Expert Outlook On Legend Biotech Through 6 Analysts
↗
July 02, 2025
Via
Benzinga
The FDA Shake-Up Continues, And Could Impact Genetic Medicines
↗
June 20, 2025
Nicole Verdun and Rachael Anatol were placed on administration leave without explanation.
Via
Investor's Business Daily
Topics
Government
Is Legend Biotech Gaining or Losing Market Support?
↗
June 12, 2025
Via
Benzinga
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
↗
June 10, 2025
Via
Benzinga
Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday
↗
June 06, 2025
Via
Benzinga
What Does the Market Think About Legend Biotech?
↗
April 29, 2025
Via
Benzinga
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
June 03, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
May 22, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
May 19, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Is Legend Biotech Gaining or Losing Market Support?
↗
March 05, 2025
Via
Benzinga
Peering Into Legend Biotech's Recent Short Interest
↗
February 17, 2025
Via
Benzinga
Where Legend Biotech Stands With Analysts
↗
January 23, 2025
Via
Benzinga
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights
May 13, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
April 29, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Monday
↗
April 15, 2025
Via
Benzinga
Breaking Down Legend Biotech: 9 Analysts Share Their Views
↗
December 30, 2024
Via
Benzinga
(LEGN) - Analyzing Legend Biotech's Short Interest
↗
December 16, 2024
Via
Benzinga
Deep Dive Into Legend Biotech Stock: Analyst Perspectives (10 Ratings)
↗
December 10, 2024
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst
↗
April 08, 2025
Legend Biotech's Carvykti shows strong efficacy in multiple myeloma as U.S.-based manufacturing shields it from tariffs and global regulatory risks.
Via
Benzinga
Topics
World Trade
5 Analysts Have This To Say About Legend Biotech
↗
April 08, 2025
Via
Benzinga
What Does the Market Think About Legend Biotech?
↗
April 03, 2025
Via
Benzinga
Demystifying Legend Biotech: Insights From 5 Analyst Reviews
↗
March 17, 2025
Via
Benzinga
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
March 11, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Earnings Scheduled For March 11, 2025
↗
March 11, 2025
Via
Benzinga
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
February 25, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
From
Legend Biotech USA Inc.
Via
GlobeNewswire
CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma
December 09, 2024
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights
November 12, 2024
From
Legend Biotech USA Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
